Purchase Order N0018317P0768
Award Date 6/13/17
Potential Completion Date 8/9/18
Potential Value $4.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Braintree, MA 02184, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Haemonetics Corporation has been awarded a $88,770 firm fixed-price purchase order by the Bureau of Medicine and Surgery to provide annual maintenance services for three TEG 5000 hemostasis analyzers at the Naval Medical Research Unit in San Antonio, Texas. The contract, awarded on September 30, 2025, extends through September 30, 2030, and was issued without a set-aside designation, indicating open competitive bidding. The TEG 5000 devices are critical diagnostic instruments used in blood...
- The federal contract award HT940623P0100, valued at $91,029.00, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the provision of implementation services. This is a firm-fixed-price purchase order contract with no set-aside designation, indicating Haemonetics' competitiveness as a large, established provider of specialized medical equipment and services to government healthcare agencies. The contract includes the supply of...
- <p>The Food and Drug Administration awarded a purchase order to Haemonetics Corporation on February 15, 2023, for a Haemonetics TEG Hemostasis Analyzer, with a ceiling value of $46,895.00. No set-aside was used. Place of performance is Boston, Massachusetts. The order has a firm fixed-price structure and an ultimate completion date of June 30, 2023.</p>
- This federal contract award is for a Firm Fixed Price Purchase Order valued at $21,300.00, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 10 (VA VISN 10) to Haemonetics Corporation, doing business as Haemonetics. The contract, which does not have a set-aside designation, is for a TEG 6S Service Agreement with a period of performance through September 30, 2023. Haemonetics is a leading provider of blood and plasma management products and services to the federal...
- The U.S. Bureau of Medicine and Surgery, a component of the Department of Defense, awarded a Firm Fixed Price Purchase Order contract to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract, valued at $84,010.00, is for the delivery of a Hemostasis Analyzer with printer, scanner, and license. This award does not have a set-aside designation. The contract award is part of a larger Indefinite Delivery Vehicle (IDV) contract between...
- This is a firm-fixed price purchase order contract awarded by the Department of Defense (DoD) Medical Command (MEDCOM) to Haemonetics Corporation, a leading medical technology company, for the provision of a HEMOSTASIS ANALYZER. The contract has a ceiling value of $81,765.00 and an ultimate completion date of October 2, 2017. This contract does not have a set-aside designation, indicating Haemonetics competed effectively as a large, established medical technology corporation. Haemonetics also...
- Haemonetics Corporation, headquartered in Boston, Massachusetts, was awarded a firm fixed-price purchase order by a civilian federal agency's Shared Services Center for portable blood analyzers, with a contract value of $131,896.12 and an ultimate completion date of July 1, 2026. The contract was awarded on a full and open competitive basis without set-aside restrictions. Performance will be executed at Haemonetics' Boston facility, leveraging the company's extensive expertise as a leading...
- This is a $9,000.00 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Haemonetics Corporation for a maintenance service agreement for laboratory analyzers and blood gas equipment. The contract was awarded on August 21, 2013 with a period of performance through August 22, 2016. This contract does not have a set-aside designation, reflecting Haemonetics' status as a large, established provider of medical...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the delivery of Lab Analyzers. The contract has a ceiling value of $71,916.00 and an ultimate completion date of October 31, 2024. There is no set-aside designation, indicating Haemonetics competed effectively as a large, established supplier. The contract is part of Haemonetics' broader portfolio of medical device and equipment supply...
- This federal contract award is for the delivery of a NUTRIENT ADDITIVE SOLUTION FORMULA to the Defense Health Agency. The prime contractor is Haemonetics Corporation, a leading medical technology company headquartered in Boston, Massachusetts. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $46,615.22 and an ultimate completion date of September 30, 2025. The contract was awarded on a full and open competitive basis, with no set-aside designation. Haemonetics...